The pharmaceutical industry has been under increasing pressure to deliver drugs to the market faster and more efficiently. In an effort to combat this, Dr Namyong Kim, who leads a team of scientists at the Institute of Bioengineering and Nanotechnology (IBN), under the Agency for Science, Technology, and Research (A*STAR) in Singapore developed the new bioassay technology called DropArray. More »

SINGAPORE National Eye Centre (SNEC) researchers are testing a new technology, touted for its ability to accurately detect eye ailments more quickly than current methods. More »

Curiox Biosystems has developed a miniaturisation platform that enables cheaper and more efficient bioassays to be conducted, potentially slashing the costs of life science and drug discovery research. More »

German nanotechnology company had decided to make a 16.5 per cent investment in a Singapore-based start up called Curiox Biosystems. Nanostart AG is widely seen as the world's leading nanotechnology investment company. More »